Navigation Links
SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil

STOUGHTON, Mass., Jan. 5, 2011 /PRNewswire/ -- SyncMedical LLC today announced that the Brazilian ANVISA (Agencia Nacional de Vigilancia Sanitaria – Brazilian National Health Surveillance Agency) has approved their Ethos Spine Pedicle Screw System for sale in Brazil. SyncMedical's Ethos Spine product line was developed to fulfill the need for quality and cost effective treatment solutions to surgeons in the ever-growing, ever-changing field of spine surgery. The Ethos Spine product line provides U.S. manufactured minimally invasive solutions to fit the needs of the global medical community. Ethos product offerings include the Ethos C-Spacer, the Ethos PEEK VBR System and the above mentioned Ethos Pedicle Screw System.

Earlier this month SyncMedical also received ANVISA approval for the Spirus Medical Endo-Ease Discovery System.  SyncMedical is the exclusive Latin American distributor for Spirus Medical, Inc. a core product line of SyncMedical's Internal Medicine Division.

Spirus Medical, Inc. is a leader in bringing novel innovations to the GI market. The company pioneered the concept of "spiral endoscopy" with the introduction of the Endo-Ease Discovery ® SB for deep enteroscopy and the Vista® Retrograde for colonoscopy and ileoscopy. These rotate-to-advance technologies utilize a spiral element on an over-tube to advance and anchor medical devices in natural orifices of the body or a surgically created opening. The company is presently developing a flexible endoscope with an integral drive to power a single use spiral component.

SyncMedical LLC

SyncMedical LLC is an affiliated company of STD Med, Inc. SyncMedical develops, produces and markets medical devices exclusively for regions outside of the United States by leveraging its strategic partnerships with industry leaders and medical professionals. SyncMedical is focused on developing access to the next generation of medical innovations. Our product development partners and our global team of representatives work together at every stage to provide solutions for the international medical community.

STD Med, Inc.

STD Med, Inc. is a rapidly growing and emerging leader in the development and manufacture of medical devices and precision machined components. Established in 1953, STD Med, Inc. is a privately held company. Over the past several years STD Med, Inc. has incubated and invested in several new technologies including Angiolink Corporation (acquired by Medtronic), Arthrosurface Inc., Spirus Medical, Inc. and Cardiosolutions, Inc. and it is our intention to continue to pursue disruptive innovation in the medical device marketplace.

SOURCE SyncMedical LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Italian Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
(Date:11/25/2015)... MINNEAPOLIS , Nov. 25, 2015  ARKRAY ... care products, continues to provide evidence demonstrating the accuracy ... the World Congress on Insulin Resistance, Diabetes and Cardiovascular ... showed that both the Company,s GLUCOCARD ® 01 ... met high accuracy requirements. The ability to accurately measure ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... 2015 , ... Somu Sivaramakrishnan announced today that he joined ... offers travelers, value and care based Travel Services, including exclusive pricing on a ... cabin upgrades and special amenities such as, shore excursions, discounted fares, travel gifts ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack ... trailer titles work with any font, giving users limitless opportunities to stylize and ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season ... and pleasing the palates of attendees is of the utmost importance. Whether you ... seasonal get-together, give these recipes a try this holiday season. , Turkey Croquettes ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and public R&D ... Nairobi (UNON) for the opening of the 5th African Network for Drugs and ...
(Date:11/25/2015)... Cleveland, OH (PRWEB) , ... November 25, 2015 , ... ... dental implants in Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced ... 5th this year in Cleveland, OH. , As the co-founders of Advanced Implant ...
Breaking Medicine News(10 mins):